Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Neal

Showing results (221-230 of 260) with videos related to

Pageof 26
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 1, 2020
Defining trauma-induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTHHunter B Moore, Satoshi Gando, Toshiaki Iba, et al.
Research Square|January 14, 2021
Lipidomic Signatures Align with Inflammatory Patterns and Outcomes in Critical IllnessJunru Wu, Anthony Cyr, Danielle S Gruen, et al.
Seminars in Thrombosis and Hemostasis|September 29, 2022
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical IllnessLize M Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Science Advances|September 13, 2021
Platelets amplify endotheliopathy in COVID-19Tessa J Barrett, MacIntosh Cornwell, Khrystyna Myndzar, et al.
Journal of the American Heart Association|May 6, 2026
Soluble Thrombomodulin Links Viremia and Mortality During COVID-19: Results From the ACTIV-4a TrialBenjamin E Zuchelkowski, Kyle W Inman, S Mehdi Nouraie, et al.
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Cell Reports. Medicine|March 19, 2025
High-dimensional analysis of injured patients reveals distinct circulating proteomic profiles in plasma vs. whole blood resuscitationHamed Moheimani, Xuejing Sun, Mehves Ozel, et al.
The Journal of Trauma and Acute Care Surgery|April 30, 2024
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter studyJordan M Estroff, Joseph Devlin, Lara Hoteit, et al.
Research and Practice in Thrombosis and Haemostasis|September 20, 2023
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trialNathaniel R Smilowitz, Erinn M Hade, Lucy Z Kornblith, et al.
The Journal of Trauma and Acute Care Surgery|September 16, 2025
The use of tranexamic acid in the management of injured patients at risk of hemorrhage: a systematic review and meta-analysis and an Eastern Association for the Surgery of Trauma Practice Management GuidelineRyan P Dumas, Bahaa E Succar, Michael A Vella, et al.
Pageof 26

Showing results (221-230 of 260) with videos related to

Sort By:
Pageof 26
Journal of Thrombosis and Haemostasis : JTH|March 1, 2020
Defining trauma-induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTHHunter B Moore, Satoshi Gando, Toshiaki Iba, et al.
Research Square|January 14, 2021
Lipidomic Signatures Align with Inflammatory Patterns and Outcomes in Critical IllnessJunru Wu, Anthony Cyr, Danielle S Gruen, et al.
Seminars in Thrombosis and Hemostasis|September 29, 2022
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical IllnessLize M Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Science Advances|September 13, 2021
Platelets amplify endotheliopathy in COVID-19Tessa J Barrett, MacIntosh Cornwell, Khrystyna Myndzar, et al.
Journal of the American Heart Association|May 6, 2026
Soluble Thrombomodulin Links Viremia and Mortality During COVID-19: Results From the ACTIV-4a TrialBenjamin E Zuchelkowski, Kyle W Inman, S Mehdi Nouraie, et al.
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Cell Reports. Medicine|March 19, 2025
High-dimensional analysis of injured patients reveals distinct circulating proteomic profiles in plasma vs. whole blood resuscitationHamed Moheimani, Xuejing Sun, Mehves Ozel, et al.
The Journal of Trauma and Acute Care Surgery|April 30, 2024
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter studyJordan M Estroff, Joseph Devlin, Lara Hoteit, et al.
Research and Practice in Thrombosis and Haemostasis|September 20, 2023
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trialNathaniel R Smilowitz, Erinn M Hade, Lucy Z Kornblith, et al.
The Journal of Trauma and Acute Care Surgery|September 16, 2025
The use of tranexamic acid in the management of injured patients at risk of hemorrhage: a systematic review and meta-analysis and an Eastern Association for the Surgery of Trauma Practice Management GuidelineRyan P Dumas, Bahaa E Succar, Michael A Vella, et al.
Pageof 26